1-[6-(Diethoxyphosphinyl)-2-O-methyl-β-D-ribo-hexofuranosyl]uracil
CAT:
804-HY-154587
Size:
Inquire
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
![1-[6-(Diethoxyphosphinyl)-2-O-methyl-β-D-ribo-hexofuranosyl]uracil - image 1](/gentaur-product-1.webp)
![1-[6-(Diethoxyphosphinyl)-2-O-methyl-β-D-ribo-hexofuranosyl]uracil - image 1](/gentaur-product-1.webp)
1-[6-(Diethoxyphosphinyl)-2-O-methyl-β-D-ribo-hexofuranosyl]uracil
UNSPSC Description:
1-[6-(Diethoxyphosphinyl)-2-O-methyl-β-D-ribo-hexofuranosyl]uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].Target Antigen:
Nucleoside Antimetabolite/AnalogType:
OligonucleotidesRelated Pathways:
Cell Cycle/DNA DamageApplications:
Cancer-programmed cell deathField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/1-6-diethoxyphosphinyl-2-o-methyl-β-d-ribo-hexofuranosyl-uracil.htmlSolubility:
10 mM in DMSOSmiles:
O[C@H]1[C@@H](OC)[C@H](N2C(NC(C=C2)=O)=O)O[C@@H]1CCP(OCC)(OCC)=OMolecular Weight:
392.34References & Citations:
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.Shipping Conditions:
Room temperatureClinical Information:
No Development ReportedCAS Number:
2095417-38-0